Inhibition of GCH1 by 2,4-diamino-6-hydroxypyrimidine could block IDO1 activity, halt tumor growth, and enhance the tumor response to anti-PD-1 immunotherapy [38]. This evidence concerns the gene PDCD1 and neoplasm.